| View |
|
DRP-10899
|
Ezetimibe
|
Ezemibe
|
10 mg
|
Tablet
|
Lipid Modifying Agent (Cholesterol Absorption
Inhibitor)
|
Medisure Laboratories Pakistan (Pvt.) Ltd.
|
Pakistan
|
Initial
|
13 December 2021
|
13 December 2026
|
| View |
|
DRP-8399-03
|
Amino Acid + Sorbitol
|
Ambisor
|
Each 100 mL contains:
Glycine
760 mg L-Phenylalanine
533 mg L-Arginine Hydrochloride
500 mg L-Leucine
490 mg L-Lysine Hydrochloride
430 mg L-Valine
360 mg L-Isoleucine
352 mg L-Aspartic Acid L-Histidine Hydrochloride L-Threonine
250 mg
L-Methionine L-Alanine L-Proline L-Serine L-Tryptophan
225 mg 200 mg 100 mg 100 mg 90 mg 75 mg 25 mg 10 mg 5 mg
250 mg 250 mg
L-Tyrosine L-Cystine Sorbitol
500mL
500mL
|
Total Parenteral Nutrition
|
Total Parenteral Nutrition
|
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
14 March 2024
|
20 March 2029
|
| View |
|
DRP-10897
|
Losartan Potassium + Hydrochlorothiazide
|
Natrasol Plus
|
100 mg/25 mg
|
Film-Coated Tablet
|
-
|
Centurion Laboratories Pvt. Ltd
|
India
|
-
|
13 December 2021
|
13 December 2026
|
| View |
|
DRP-3495-04
|
Amlodipine (As Besilate)
|
TG Amlodimax
|
10mg
|
Film-Coated Tablet
|
Calcium Channel Blocker
|
JM Tolmann Laboratories, Inc.
|
Philippines
|
Initial [CLIDP)
|
07 December 2021
|
26 August 2026
|
| View |
|
DRP-3264-12
|
Paracetamol / Vitamin B1 / Vitamin B6 / Vitamin B12
|
Neurogold
|
500 mg / 50 mg 100 mg/ 100 mcg
|
Film-Coated Tablet
|
Analgesic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
20 May 2022
|
20 May 2027
|
| View |
|
DRP-7111-08
|
Iron (as Ferric Hydroxide Sucrose Complex)
|
Irsuc
|
20mg/mL (100mg/5mL)
|
Solution for Injection (IV)
|
Hematinic
|
Alwin DMD Pharmaceuticals
|
India
|
Renewal
|
10 May 2022
|
17 March 2027
|
| View |
|
DRP-7335-06
|
Vancomycin (as hydrochloride)
|
Vancocym 500
|
500mg
|
Powder for Solution for IV Infusion
|
Glycopeptide Antibacterial
|
Alwin DMD Pharmaceuticals
|
India
|
Renewal
|
10 August 2022
|
18 March 2027
|
| View |
|
DRP-1391-02
|
Fenofibrate
|
None
|
160 mg
|
Tablet
|
Lipid Modifying Agent (Fibrate)
|
Sun Pharmaceutical Industries Limited
|
India
|
Automatic Renewal (E-AR)
|
03 January 2024
|
23 April 2028
|
| View |
|
DRP-4838-05
|
Fenofibrate
|
Fenocare
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
25 January 2024
|
16 October 2028
|
| View |
|
DRP-10876
|
Sevelamer Carbonate
|
Nefral
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Globela Pharma Private Limited
|
India
|
Initial
|
10 December 2021
|
10 December 2026
|
| View |
|
DRP-10898
|
Losartan potassium + Hydrochlorothiazide
|
Natrasol Plus
|
50 mg/12.50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)/Diuretic
|
Centurion Laboratories Pvt. Ltd.
|
India
|
Initial
|
13 December 2021
|
13 December 2026
|
| View |
|
DRP-10877
|
Sevelamer Carbonate
|
Sevlorx
|
800 mg
|
Film-Coated Tablet
|
Phosphate Binder
|
Globela Pharma Private Limited
|
India
|
Initial
|
10 December 2021
|
10 December 2026
|
| View |
|
DRHR-2110
|
Camphor + Menthol + Eucalyptus Oil
|
Mama'S Love Mentholated Vapor Rub
|
7.2 g / 4.0 g / 4.0 g per 100 g
|
Ointment
|
-
|
International Pharmaceuticals, Inc.
|
Philippines
|
-
|
07 December 2021
|
07 December 2024
|
| View |
|
DRHR-2111
|
Camphor + Menthol+ Eucalyptus Oil
|
Mama's Touch Mentholated Vapor Rub - Citrus
|
7.20 g/ 4 g/4 g per 100 g
|
Ointment
|
Counterirritant
|
International Pharmaceuticals, Inc.
|
Philippines
|
Initial (HR)
|
07 December 2021
|
07 December 2024
|
| View |
|
DRP-10857
|
Oxaliplatin
|
VEXPLATIN VE-50
|
5 mg/mL (50 mg/10 mL)
|
Solution for Injection
(IV Infusion)
|
Antineoplastic
|
Venus Remedies Limited
|
India
|
Renewal
|
09 November 2024
|
09 December 2031
|
| View |
|
DRP-10856
|
Oxaliplatin
|
VEXPLATIN VE-100
|
5 mg/mL (100 mg/20 mL)
|
Solution for Injection
(IV Infusion)
|
Antineoplastic
|
Venus Remedies Limited
|
India
|
Renewal
|
09 November 2024
|
09 December 2031
|
| View |
|
DRHR-2112
|
Aceite de Manzanilla
|
Mama'S Love
|
500mcg/mL
|
Solution
|
Antiflatulent
|
International Pharmaceuticals, Inc.
|
Philippines
|
Automatic Renewal
|
26 July 2023
|
10 December 2028
|
| View |
|
DRHR-2108
|
Ethyl Alcohol
|
Casino - Unscented
|
70mL per 100mL (70% v/v)
|
Solution
|
-
|
International Pharmaceuticals, Inc
|
Philippines
|
-
|
02 December 2021
|
02 December 2026
|
| View |
|
DRP-3199-07
|
Telmisartan + Hydrochlorothiazide
|
Onmarc-H
|
40 mg/ 12.5 mg
|
Tablet
|
Angiotensin Il Receptor Blocker/Diuretic
|
Theon Pharmaceuticals Ltd.
|
India
|
Initial
|
02 December 2021
|
23 August 2026
|
| View |
|
DRP-10836
|
Ascorbic Acid + Zinc
|
None
|
500mg (equivalent to 562.4mg Sodium
Ascorbate)/10mg (equivalent to 27.5mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/Mineral
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
Initial (OTC)(PCPR)
|
02 December 2021
|
02 December 2026
|